Leaflet BOSENTAN SANDOZ 125mg film-coated tablets
Indicated for: pulmonary arterial hypertension
Route of administration: oral
Substance: bosentan (vasodilator)
ATC: C02KX01 (Cardiovascular system | Other antihypertensives | Antihypertensives for pulmonary arterial hypertension)
This medicine may affect fertility.
This medicine may cause dizziness or vertigo.
Effective contraception is required during treatment.
Do not use this medicine during pregnancy.
May lower blood pressure and increase the risk of falls.
This medicine may affect fetal development.
Bosentan is a medication used for the treatment of pulmonary arterial hypertension (PAH), a condition characterized by increased pressure in the pulmonary arteries. It is an endothelin receptor antagonist that helps relax blood vessels and reduce blood pressure.
The medication is taken orally, usually twice daily, as directed by a doctor. The treatment requires regular monitoring, including blood tests to assess liver function.
Common side effects include headaches, edema, fatigue, and elevated liver enzyme levels. In rare cases, more severe adverse effects such as liver failure or anemia may occur.
Bosentan is not recommended for pregnant women, as it may cause birth defects. Patients should use effective contraception during treatment and inform their doctor about any other medications they are taking to avoid drug interactions.
General data about BOSENTAN SANDOZ 125mg
- Substance: bosentan
- Date of latest medicines list: 01-08-2018
- Product code: W64638001
- Concentration: 125mg
- Pharmaceutical form: film-coated tablets
- Quantity: 14
- Product type: Generic medicine
- Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Concentrations available for bosentan
- 125mg
- 62.5mg